Camden National Corporation’s Idexx Laboratories IDXX Stock Holding History

Camden National Corporation’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$516K	Buy	+1,055	New	+$529K	0.1%	91

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Camden National Corporation's IDXX Position: Q1 2021 in Review

Camden National Corporation opened a new position in Idexx Laboratories (IDXX) in Q1 2021: 1,055 shares worth $516K. The stake represents 0.1% of the portfolio and ranks #91 among its holdings.

1,012 funds tracked by Wall St. Rank hold IDXX as of Q1 2021.

Camden National Corporation held 1,055 shares of Idexx Laboratories worth $516K as of Q1 2021.
Idexx Laboratories was a new Camden National Corporation position in Q1 2021.
Idexx Laboratories made up 0.1% of Camden National Corporation's portfolio in Q1 2021, its #91 holding.
1,012 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2021.

Based on Camden National Corporation's 13F filing for Q1 2021, filed 12 May 2021.